TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GNLX

Genelux Corporation

Healthcare · Biotechnology

2.60$ +1.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GNLX
Line item 2019 2020 2021 2022 2023 2024 2025
0.00 0.00 0.45 0.01 0.00 0.00
0.02 0.03 0.04 0.04 0.04 0.03 0.02
-0.02 -0.03 -0.04 0.41 -0.03 -0.03 -0.02
0.32 0.26 0.27 0.37 0.52 0.60 0.53
0.13 0.26 0.35 0.20 0.47 0.40 0.36
0.46 0.50 0.58 0.53 0.95 0.98 0.88
-0.46 -0.53 -0.62 -0.12 -0.99 -1.01 -0.89
0.03 0.05 0.08 0.06 0.16 0.00
-0.49 -0.58 -0.69 -0.17 -1.16 -0.95 -0.86
0.05 0.06 0.04 0.03
-0.49 -0.63 -0.75 -0.21 -1.16 -0.95 -0.86
-0.44 -0.50 -0.58 -0.07 -1.08 -0.92 -0.85

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?